TrialPloS one2023

Efficacy and safety of GSK3772847 in participants with moderate-to-severe asthma with allergic fungal airway disease: A phase IIa randomized, multicenter, double-blind, sponsor-open, comparative trial.

Chika Akinseye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.